Cargando…

Effect of subthalamic nucleus deep brain stimulation on dual-task cognitive and motor performance in isolated dystonia

OBJECTIVE: Subthalamic nucleus (STN) deep brain stimulation (DBS) can improve motor complications of Parkinson's disease (PD) but may worsen specific cognitive functions. The effect of STN DBS on cognitive function in dystonia patients is less clear. Previous reports indicate that bilateral STN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mills, Kelly A, Markun, Leslie C, Luciano, Marta San, Rizk, Rami, Allen, I Elaine, Racine, Caroline A, Starr, Philip A, Alberts, Jay L, Ostrem, Jill L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Movement Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392192/ https://www.ncbi.nlm.nih.gov/pubmed/25012202 http://dx.doi.org/10.1136/jnnp-2014-307942

Ejemplares similares

Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson's disease using an MRI-guided and MRI-verified approach
por: Aviles-Olmos, Iciar, et al.
Publicado: (2014)

Psychiatric associations of adult-onset focal dystonia phenotypes
por: Berman, Brian D, et al.
Publicado: (2017)

Rest and other types of tremor in adult-onset primary dystonia
por: Erro, Roberto, et al.
Publicado: (2014)

Pathogenesis of dystonia: is it of cerebellar or basal ganglia origin?
por: Kaji, Ryuji, et al.
Publicado: (2018)

Selective peripheral denervation for cervical dystonia: long-term follow-up
por: Bergenheim, A Tommy, et al.
Publicado: (2015)

Long‐term independence and quality of life after subthalamic stimulation in Parkinson disease
por: Castrioto, Anna, et al.
Publicado: (2022)

Risk of spread in adult-onset isolated focal dystonia: a prospective international cohort study
por: Berman, Brian D, et al.
Publicado: (2020)

Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease
por: Sauerbier, Anna, et al.
Publicado: (2021)

Structural magnetic resonance imaging in dystonia: A systematic review of methodological approaches and findings
por: MacIver, Claire L., et al.
Publicado: (2022)

Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia
por: Dressler, Dirk, et al.
Publicado: (2013)

Differences in globus pallidus neuronal firing rates and patterns relate to different disease biology in children with dystonia
por: McClelland, V M, et al.
Publicado: (2016)

Adult‐onset idiopathic dystonia: A national data‐linkage study to determine epidemiological, social deprivation, and mortality characteristics
por: Bailey, Grace A., et al.
Publicado: (2021)

Systematic review of data‐driven cognitive subtypes in Parkinson disease
por: Pourzinal, Dana, et al.
Publicado: (2022)

Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia
por: Fernandez, Hubert H, et al.
Publicado: (2019)

Neuromodulation of the subthalamic nucleus in Parkinson’s disease: the effect of fiber tract stimulation on tremor control
por: Abdulbaki, Arif, et al.
Publicado: (2020)

The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease
por: Barker, Roger A, et al.
Publicado: (2013)

Functional connectivity and topology in patients with restless legs syndrome: a case–control resting‐state functional magnetic resonance imaging study
por: Tuovinen, N., et al.
Publicado: (2020)

Management of rare movement disorders in Europe: outcome of surveys of the European Reference Network for Rare Neurological Diseases
por: Painous, C., et al.
Publicado: (2020)

Hand Stereotypies in Rett Syndrome
por: Ferreira, Matheus G., et al.
Publicado: (2020)

Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
por: Swallow, Diane M A, et al.
Publicado: (2016)

Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with ((123)I) ioflupane in diagnosis of parkinsonian syndromes
por: Bajaj, Nin, et al.
Publicado: (2013)

Features of GBA-associated Parkinson’s disease at presentation in the UK Tracking Parkinson’s study
por: Malek, Naveed, et al.
Publicado: (2018)

Stability of mild cognitive impairment in newly diagnosed Parkinson's disease
por: Lawson, Rachael A, et al.
Publicado: (2017)

Shorter pulse width reduces gait disturbances following deep brain stimulation for essential tremor
por: Kroneberg, Daniel, et al.
Publicado: (2019)

From trials to clinical practice: Temporal trends in the coverage of specialized allied health services for Parkinson's disease
por: Bloem, Bastiaan R., et al.
Publicado: (2020)

Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
por: Lawton, Michael, et al.
Publicado: (2018)

Effects of TPH2 gene variation and childhood trauma on the clinical and circuit-level phenotype of functional movement disorders
por: Spagnolo, Primavera A, et al.
Publicado: (2020)

Thermal hypesthesia in patients with complex regional pain syndrome related dystonia
por: Munts, Alexander G., et al.
Publicado: (2010)

The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders
por: Rittman, Timothy, et al.
Publicado: (2013)

Systematic clinical approach for diagnosing upper limb tremor
por: van de Wardt, Jaron, et al.
Publicado: (2020)

Impact of GBA1 variants on long-term clinical progression and mortality in incident Parkinson’s disease
por: Stoker, Thomas B, et al.
Publicado: (2020)

Visual dysfunction is a better predictor than retinal thickness for dementia in Parkinson’s disease
por: Hannaway, Naomi, et al.
Publicado: (2023)

Establishing diagnostic criteria for Perry syndrome
por: Mishima, Takayasu, et al.
Publicado: (2018)

Multicentre, randomised controlled trial of PDSAFE, a physiotherapist-delivered fall prevention programme for people with Parkinson’s
por: Chivers Seymour, Kim, et al.
Publicado: (2019)

Parkinson’s disease determinants, prediction and gene–environment interactions in the UK Biobank
por: Jacobs, Benjamin Meir, et al.
Publicado: (2020)

Botulinum neurotoxin treatment in jerky and tremulous functional movement disorders: a double-blind, randomised placebo-controlled trial with an open-label extension
por: Dreissen, Yasmine Emma Maria, et al.
Publicado: (2019)

Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts
por: Lawton, Michael, et al.
Publicado: (2022)

Combining biomarkers for prognostic modelling of Parkinson’s disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022)

The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism
por: Klebe, Stephan, et al.
Publicado: (2013)

Visual hallucinations in the differential diagnosis of parkinsonism
por: Bertram, Kelly, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_351i5cdfv27seqbshuhf1a95lo